Barriers preventing liver transplantation in Canadians with HIV infection - Perceptions of HIV specialists

Canadian Journal of Gastroenterology

Volumn 21, Issue 3, 2007, Pages 179-182

  Cooper, Curtis L ^a   DeForest, Joanne ^b   Gill, John ^b   Lalonde, Richard ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Alcohol; HBV; HCV; HIV; Liver; Transplantation

Indexed keywords

ALCOHOL LIVER DISEASE; ARTICLE; CANADA; COMORBIDITY; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE NEED; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; REINFECTION; RISK FACTOR; SURGEON; DONOR; EPIDEMIOLOGY; HEALTH CARE DELIVERY; HEALTH PERSONNEL ATTITUDE; VIRUS HEPATITIS;

ATTITUDE OF HEALTH PERSONNEL; CANADA; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HEPATITIS, ALCOHOLIC; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; LIVER TRANSPLANTATION; TISSUE DONORS;

EID: 34249945068     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/769752     Document Type: Article

References (26)

1. Belle SH, Porayko MK, Hoofnagle JH, Lake JR, Zetterman RK. Changes in quality of life after liver transplantation among adults. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LDT). Liver Transpl Surg 1997;3:93-104.
2. Stock PG, Roland ME, Carlson L, et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: A pilot safety and efficacy study. Transplantation 2003;76:370-5.
3. Ragni MV, Belle SH, Im K, et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003;188:1412-20.
4. Furukawa H, Todo S. Evolution of immunosuppression in liver transplantation: Contribution of cyclosporine. Transplant Proc 2004;36:274S-84S.
5. Moser MA. Options for induction immunosuppression in liver transplant recipients. 2002;62:995-1011.
6. Lok AS. Prevention of recurrent hepatitis B post-liver transplantation. Liver Transpl 2002;8:S67-73.
7. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002;8:S14-8.
8. Testa G, Crippin JS, Netto GJ, et al. Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients. Liver Transpl 2000;6:553-61.
9. Tolan DJ, Davies MH, Millson CE. Fibrosing cholestatic hepatitis after liver transplantation in a patient with hepatitis C and HIV infection. N Engl J Med 2001;345:1781.
10. Samuel D, Bizollon T, Feray C, et al. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized study. Gastroenterology 2003;124:642-50.
11. Steinbrook R. Public solicitation of organ donors. N Engl J Med 2005;353:441-4.
12. Gridetli B, Remuzzi G. Strategies for making more organs available for transplantation. N Engl J Med 2000;343:404-10.
13. Keeffe EB. Liver transplantation: Current status and novel approaches to liver replacement, Gastroenterology 2001;20:749-62.
14. McAlister VC, Badovinac K, Fenton SS, Greig PD. Transplantation in Canada: Review of the last decade from the Canadian Organ Replacement Register. Clin Transpl 2003:101-8.
15. Prachalias AA, Pozniak A, Taylor C, et al. Liver transplantation in adults coinfected with HIV Transplantation 2001;72:1684-8.
16. Neff GW, Bonham A, Tzakis AG, et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003;9:239-47.
17. Norris S, Taylor C, Muiesan P, et al. Outcomes of liver transplantation in HIV-infected individuals: The impact of HCV and HBV infection. Liver Transpl 2004;10:1271-8.
18. Consensus conference: Indications for Liver Transplantation, January 19 and 20, 2005, Lyon-Palais Des Congres: Text of recommendations (long version). Liver Transpl 2006;12:998-1011.
19. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001;32:492-7.
20. National HIV Prevalence and Incidence Estimates for 2002-HIV/AIDS Epi Update, Ottawa: Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, 2005.
21. Oliveros FH, Santamaria ML, Gamez M, et al. Comparative study between living and cadaveric donors in pediatric liver transplantation. Transplant Proc 2005;37:3936,8.
22. Elola-Olaso AM, Gonzalez EM, Diaz JC, et al. Short and long-term outcomes after living donor liver transplantation. Transplant Proc 2005;37:3884-6.
23. Sugawara Y, Ohkubo T, Makuuchi M, et al. Living-donor liver transplantation in an HIV-positive patient with hemophilia, Transplantation 2002;74:1655-6.
24. Rodriguez-Luna H, Douglas DD. Natural history of hepatitis C following liver transplantation. Curr Opin Infect Dis 2004;17:363-71.
25. Halpern SD, Asch DA, Shaked A, Stock PG, Blumberg E. Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIV Am J Transplant 2005;5:1319-25.
26. Allard R, Turmel B, Venne S, et al. Portrait des infections transmissibles sexuellement et par le sang (ITSS), De L'Hépatite C, De L'Infection Par Le VIH et du sida au Québec. Collection Analyses et Surveillance. Quebec: Ministére de la Santé et Services sociaux Quebec, 2004.